Showing 2741-2750 of 20896 results for "".
- Enhancing Maternal Health: The Role of Education, ICTs, and Economic Empowermenthttps://reachmd.com/news/enhancing-maternal-health-the-role-of-education-icts-and-economic-empowerment/2471620/Maternal health remains a critical indicator of a nation’s well-being. By integrating women’s education, ICT innovations, and improved income levels, significant strides can be made in reducing maternal mortality and achieving sustainable health outcom
- 2025 AAD: Physosocial Implications of Neuromodulator Injectionshttps://reachmd.com/news/2025-aad-physosocial-implications-of-neuromodulator-injections/2473760/The “Botulinum Toxins: The Latest Updates” session at the 2025 American Academy of Dermatology (AAD) Annual Meeting concluded with Vince Bertucci, MD, FAAD, discussing the topic of “Physosocial Implications of Neuromodulator Injections.” Dr. Bertucci explained the facial feedbac
- Interim Analysis: Dupilumab Reduces Itch, Pain in Ichthyosis and EBhttps://reachmd.com/news/Interim-Analysis-Dupilumab-Reduces-Itch-Pain-Ichthyosis-EB/2471652/Dupilumab reduced both itch and pain in congenital ichthyosis and epidermolysis bullosa (EB), with no new safety issues, in an interim analysis presented during the late-breakers sessions at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida. Medical student
- Unraveling the Gender Disparity in Scleroderma: New Biological Insights and Emerging Treatmentshttps://reachmd.com/news/unraveling-the-gender-disparity-in-scleroderma-new-biological-insights-and-emerging-treatments/2471557/Recent studies from the Hospital for Special Surgery reveal how differences in immune system regulation between males and females contribute to a higher prevalence of scleroderma in women, opening avenues for targeted therapies. Scleroderma, or
- Exploring the Impact of Social Vulnerability on Long COVID Outcomes in Minority Populationshttps://reachmd.com/news/exploring-the-impact-of-social-vulnerability-on-long-covid-outcomes-in-minority-populations/2471616/Recent research has revealed that higher social vulnerability scores among minority populations are linked with increased incidences of long COVID. These findings underscore the influence of socioeconomic factors—including housing instability, limited healthcare ac
- Illuminating the Future: How f-ORG is Revolutionizing Early Detection of Retinal Diseaseshttps://reachmd.com/news/illuminating-the-future-how-f-org-is-revolutionizing-early-detection-of-retinal-diseases/2471640/Illuminating the Future: How f-ORG is Revolutionizing Early Detection of Retinal Diseases A Visionary Leap in Retinal Diagnostics with f-ORG and STOC-T Recent advancements in ophthalmologic imaging have ushered in groundbreaking diagnostic methodologies. F
- Innovative MRI-Based 3D Node Mapping in Rectal Cancer: Bridging Imaging and Pathologyhttps://reachmd.com/news/innovative-mri-based-3d-node-mapping-in-rectal-cancer-bridging-imaging-and-pathology/2471568/Overview and Relevance At the intersection of oncology and radiology, this new MRI-based 3D node mapping technique marks a significant breakthrough in the diagnostic process for rectal cancer. Its key discovery – improving the
- Revolutionizing Fetal Ultrasound: Enhancing Image Quality in Low-Resource Settings Using Super-Resolution Modelshttps://reachmd.com/news/revolutionizing-fetal-ultrasound-enhancing-image-quality-in-low-resource-settings-using-super-resolution-models/2471599/Amid challenges in low-resource care, advanced super-resolution models have demonstrated promising improvements in fetal ultrasound image quality, enhancing anatomical plane recognition and supporting more accurate prenatal diagnostics. Breakth
- New Study Identifies Key Pain Pathways in TMJ Disordershttps://reachmd.com/news/new-study-identifies-key-pain-pathways-in-tmj-disorders/2471648/Advanced Imaging Reveals Neural Activity Behind TMJ Pain A recent study has provided deeper insights into the pain mechanisms associated with temporomandibular joint (TMJ) disor
- Harnessing IgE Immunotherapy: A New Frontier in Overcoming HER2-Expressing Cancer Resistancehttps://reachmd.com/news/harnessing-ige-immunotherapy-a-new-frontier-in-overcoming-her2-expressing-cancer-resistance/2471646/Recent preclinical findings demonstrate that IgE antibodies present a potential strategy to tackle HER2-expressing breast and ovarian cancers resistant to conventional IgG-based therapies. The advent of IgE immunotherapy signifies a pivotal evol